Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Minimal decrease in hot flashes desired by postmenopausal women in family practice.

Debra A Butt1, Linda Y R Deng, Jacqueline E Lewis

  • 1Scarborough Hospital, Department of Family and Community Medicine, University of Toronto, Ontario, Canada. dbutt@tsh.to

Menopause (New York, N.Y.)
|November 14, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Determining Optimal Fractionation of Neoadjuvant Radiation in Low-Risk, Early-Stage Breast Cancer-Randomized SIGNAL Clinical Trial.

Cancers·2026
Same author

Comparative Efficacy of Stereotactic Body RadioTherapy (SBRT) and Percutaneous Radiofrequency Ablation (RFA) for Oligometastatic Liver Disease - Radiation Oncologists' Perspective and Practice Guideline.

The British journal of radiology·2026
Same author

Prescription patterns of inhaler medications from 2017 to 2023: A retrospective study using Ontario administrative healthcare data.

PloS one·2026
Same author

A comparison of contrast-to-noise ratio of liver tumors between dynamic contrast-enhanced (DCE) CT and respiration-tracked 4D-CT for radiotherapy targeting.

The British journal of radiology·2026
Same author

Trends in pulmonary exercise testing utilization after the COVID-19 pandemic in Ontario: A population-cohort study.

PloS one·2026
Same author

Healthcare use in individuals with and without attention-deficit/hyperactivity disorder: A population-based longitudinal matched cohort study.

PLOS mental health·2026
Same journal

Combined adductor pollicis muscle thickness and handgrip strength as predictive indicators for risk stratification of low muscle mass and low bone mass in adult women.

Menopause (New York, N.Y.)·2026
Same journal

Novel and traditional anthropometric measures of obesity association with dynapenia in postmenopausal women.

Menopause (New York, N.Y.)·2026
Same journal

Regulatory awareness, counseling priorities, and treatment choices in menopausal hormone therapy: a cross-sectional survey of obstetricians and gynecologists.

Menopause (New York, N.Y.)·2026
Same journal

Menopause Step-by-Step: must-know studies.

Menopause (New York, N.Y.)·2026
Same journal

Processed foods in the context of a vegan diet, and changes in body weight and severe hot flashes in postmenopausal women: a secondary analysis of a randomized clinical trial.

Menopause (New York, N.Y.)·2026
Same journal

Female and male factors associated with female sexual function in couples aged 50-70 years: a cross-sectional study.

Menopause (New York, N.Y.)·2026
See all related articles

Postmenopausal women desire at least a 50% reduction in hot flash frequency and severity from nonhormonal agents. This finding is crucial for developing effective anti-hot flash treatments and clinical trial designs.

Area of Science:

  • Reproductive Medicine
  • Women's Health
  • Clinical Pharmacology

Background:

  • Hot flashes are a common symptom experienced by postmenopausal women.
  • Current treatments for hot flashes include hormonal and nonhormonal agents.
  • Understanding patient-desired outcomes is essential for treatment efficacy.

Purpose of the Study:

  • To determine the minimal important difference in hot flash frequency and severity desired by postmenopausal women from a nonhormonal agent.
  • To establish a benchmark for clinical significance in hot flash management.

Main Methods:

  • Women prospectively recorded daily hot flash frequency and severity using a diary.
  • The Menopause-Specific Quality of Life Questionnaire was administered.
  • Participants reported their desired percentage reduction in hot flashes for clinical importance.

Related Experiment Videos

  • Distribution-based methods were employed to estimate the minimal important difference.

    • Main Results:

    • Approximately 69% of women with moderate to severe hot flashes desired at least a 50% mean reduction in frequency.
    • The median hot flash reduction reported by all respondents was 50%.
    • Confidence intervals for the desired reduction were 32% to 66%.

    Conclusions:

    • The minimal clinically important difference for hot flashes is approximately 50%.
    • This 50% reduction threshold can inform sample size calculations for clinical trials investigating anti-hot flash agents.
    • The findings aid in selecting promising candidates for future research in hot flash therapies.